Retatrutide is a synthetic 39-amino acid acylated peptide classified as a triple receptor agonist (GLP-1, GIP, and glucagon receptors), available as a lyophilized powder for laboratory research
It established two cohorts: 244,063 patients in the GLP-1 RA treatment group (Victoza, Saxenda, Ozempic, Wegovy) and 11,439,560 patients in the non-GLP-1 RA group
Back Capozzi, ME, DiMarchi, RD, Tschp, MH, et al (13 June 2019) Targeting the incretin/glucagon system with triagonists to treat diabetes', Endocrine Reviews , 39/5, 719-38
Many people find that focusing on liver health throughout the month leads to a more consistent feeling of wellness